These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16012312)

  • 41. Predictors of acute metabolic decompensation in children with maple syrup urine disease at the emergency department.
    Yıldız Y; Akcan Yıldız L; Dursun A; Tokatlı A; Coşkun T; Tekşam Ö; Sivri HS
    Eur J Pediatr; 2020 Jul; 179(7):1107-1114. PubMed ID: 32048023
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ophthalmoplegia and bulbar palsy in variant form of maple syrup urine disease.
    Chhabria S; Tomasi LG; Wong PW
    Ann Neurol; 1979 Jul; 6(1):71-2. PubMed ID: 507761
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A case of maple syrup urine disease misdiagnosed as tetanus neonatorum on admission.
    Kültürsay N; Kütükçüler N; Büyükgebiz B; Kleijer WJ
    Acta Paediatr Jpn; 1994 Jun; 36(3):284-6. PubMed ID: 8091979
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intermittent form of maple syrup urine disease: report of one case.
    Li PH; Ma JS; Chi CS; Mak SC
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1997; 38(6):468-71. PubMed ID: 9473820
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Eleven novel mutations of the BCKDHA, BCKDHB and DBT genes associated with maple syrup urine disease in the Chinese population: Report on eight cases.
    Li X; Ding Y; Liu Y; Ma Y; Song J; Wang Q; Li M; Qin Y; Yang Y
    Eur J Med Genet; 2015 Nov; 58(11):617-23. PubMed ID: 26453840
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intermittent maple syrup urine disease: two case reports.
    Axler O; Holmquist P
    Pediatrics; 2014 Feb; 133(2):e458-60. PubMed ID: 24394677
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Imaging in Maple Syrup Urine Disease.
    Shah T; Purohit S; Raval M
    Indian J Pediatr; 2018 Oct; 85(10):927-928. PubMed ID: 29744745
    [No Abstract]   [Full Text] [Related]  

  • 48. Second-tier test for quantification of alloisoleucine and branched-chain amino acids in dried blood spots to improve newborn screening for maple syrup urine disease (MSUD).
    Oglesbee D; Sanders KA; Lacey JM; Magera MJ; Casetta B; Strauss KA; Tortorelli S; Rinaldo P; Matern D
    Clin Chem; 2008 Mar; 54(3):542-9. PubMed ID: 18178665
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MRI findings of adult maple syrup urine disease exacerbation.
    Rawal S; Faghfoury H; Krings T
    Can J Neurol Sci; 2013 Mar; 40(2):259-62. PubMed ID: 23419580
    [No Abstract]   [Full Text] [Related]  

  • 50. [Neonatal presentation of maple syrup urine disease].
    Cardoen L; Schiff M; Lambron J; Rega A; Virlouvet AL; Biran V; Eleni Dit Trolli S; Elmaleh-Bergès M; Alison M
    Arch Pediatr; 2016 Dec; 23(12):1291-1294. PubMed ID: 27816400
    [No Abstract]   [Full Text] [Related]  

  • 51. Acrodermatitis dysmetabolica in an infant with maple syrup urine disease.
    Flores K; Chikowski R; Morrell DS
    Clin Exp Dermatol; 2016 Aug; 41(6):651-4. PubMed ID: 27334242
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Neuropathology of the maple syrup disease].
    Dambska M
    Neuropatol Pol; 1970; 8(4):349-55. PubMed ID: 5538195
    [No Abstract]   [Full Text] [Related]  

  • 53. Maple syrup urine disease presenting with neonatal status epilepticus: report of one case.
    Wang IJ; Chu SY; Wang CY; Wang PJ; Hwu WL
    Acta Paediatr Taiwan; 2003; 44(4):246-8. PubMed ID: 14674232
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of sodium phenylbutyrate treatment in acute management of maple syrup urine disease attacks: a single-center experience.
    Zubarioglu T; Dede E; Cigdem H; Kiykim E; Cansever MS; Aktuglu-Zeybek C
    J Pediatr Endocrinol Metab; 2021 Jan; 34(1):121-126. PubMed ID: 33180043
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Onset of hereditary metabolic encephalopathy can be seen after the neonatal period].
    Sørensen LC; Rehman S; Lund AM
    Ugeskr Laeger; 2016 May; 178(22):. PubMed ID: 27238151
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of a founder mutation for maple syrup urine disease in Hutterites.
    Mroch A; Davis-Keppen L; Matthes C; Stein Q
    S D Med; 2014 Apr; 67(4):141-3. PubMed ID: 24791375
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CT and MRI in maple syrup urine disease.
    Uziel G; Savoiardo M; Nardocci N
    Neurology; 1988 Mar; 38(3):486-8. PubMed ID: 3347354
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Maple syrup urine disease: further evidence that newborn screening may fail to identify variant forms.
    Puckett RL; Lorey F; Rinaldo P; Lipson MH; Matern D; Sowa ME; Levine S; Chang R; Wang RY; Abdenur JE
    Mol Genet Metab; 2010 Jun; 100(2):136-42. PubMed ID: 20307994
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Maple syrup urine disease in Brazil: a panorama of the last two decades.
    Herber S; Schwartz IV; Nalin T; Oliveira Netto CB; Camelo Junior JS; Santos ML; Ribeiro EM; Schüler-Faccini L; Souza CF
    J Pediatr (Rio J); 2015; 91(3):292-8. PubMed ID: 25512172
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Ophthalmological and histopathological findings in maple syrup disease].
    Franke G; Teuscher M; Knapp A; Seidlitz G
    Fortschr Ophthalmol; 1983; 80(6):457-9. PubMed ID: 6662450
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.